Yu-Wen Su

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Prognostic Factors

Drug Administration

Cardiovascular Events

Top Venues

Antimicrobial agents and chemotherapy

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jiong-Xian Lv, Yi-Huan Huang, Farah Kafauit, Yuan-Hui Wang, Chang Su, Jun-Heng Ma, Yan Xu, Chao-Chao Huang, Qing Zhang, Yu-Wen Su
Pharmacokinetics and pharmacodynamics of intravenous delafloxacin in healthy subjects: model-based dose optimization. Antimicrobial agents and chemotherapy (2024)
Zeng-Xiang Zhao, Tian-Yi Yang, Yuan-Hui Wang, Li Zhang, Ji Li, Yu-Wen Su
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real-world study based on the United States Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology 90 (9) (2024)
Jiong-Xian Lv, Yi-Huan Huang, Farah Kafauit, Yuan-Hui Wang, Chang Su, Jun-Heng Ma, Yan Xu, Chao-Chao Huang, Qing Zhang, Yu-Wen Su
Pharmacokinetics and pharmacodynamics of intravenous delafloxacin in healthy subjects: model-based dose optimization. Antimicrobial agents and chemotherapy 68 (7) (2024)
Jiong-Xian Lv, Yi-Huan Huang, Farah Kafauit, Yuan-Hui Wang, Chang Su, Jun-Heng Ma, Yan Xu, Chao-Chao Huang, Qing Zhang, Yu-Wen Su
Pharmacokinetics and pharmacodynamics of intravenous delafloxacin in healthy subjects: model-based dose optimization. Antimicrobial agents and chemotherapy 68 (7) (2024)
Jiong-Xian Lv, Yi-Huan Huang, Farah Kafauit, Yuan-Hui Wang, Chang Su, Jun-Heng Ma, Yan Xu, Chao-Chao Huang, Qing Zhang, Yu-Wen Su
Pharmacokinetics and pharmacodynamics of intravenous delafloxacin in healthy subjects: model-based dose optimization. Antimicrobial agents and chemotherapy 68 (7) (2024)
Zeng-Xiang Zhao, Tian-Yi Yang, Yuan-Hui Wang, Li Zhang, Ji Li, Yu-Wen Su
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real-world study based on the United States Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology 90 (9) (2024)
Zeng-Xiang Zhao, Tian-Yi Yang, Yuan-Hui Wang, Li Zhang, Ji Li, Yu-Wen Su
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real-world study based on the United States Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology (2024)